WELLINGTON MANAGEMENT GROUP LLP - DURATA THERAPEUTICS INC ownership

DURATA THERAPEUTICS INC's ticker is DRTX and the CUSIP is 26658A107. A total of 75 filers reported holding DURATA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 1.75 and the average weighting 0.6%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$25,405,000
-23.2%
2,003,570
+3.1%
0.01%
-22.2%
Q2 2014$33,079,000
+30.4%
1,942,397
+3.1%
0.01%
+28.6%
Q1 2014$25,360,000
-10.3%
1,883,244
-14.8%
0.01%
-12.5%
Q4 2013$28,257,000
+221.3%
2,209,296
+127.1%
0.01%
+166.7%
Q3 2013$8,794,000
+29.7%
972,786
+3.3%
0.00%
+50.0%
Q2 2013$6,778,000941,3000.00%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Canaan Partners VII LLC 1,902,030$24,118,00041.13%
Aisling Capital LLC 2,030,175$25,740,0004.99%
EAM Investors, LLC 187,925$2,383,0000.48%
Granahan Investment Management 691,283$8,765,0000.27%
Orbimed Advisors 1,785,714$22,643,0000.24%
Lenox Wealth Advisors, LLC 11,000$139,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 76,150$966,0000.02%
PDT Partners, LLC 61,331$778,0000.02%
MAGEE THOMSON INVESTMENT PARTNERS LLC 5,022$63,0000.02%
MASON STREET ADVISORS, LLC 148,533$1,883,0000.02%
View complete list of DURATA THERAPEUTICS INC shareholders